Intra-Cellular Therapies, Inc. (ITCI)
USD 131.87
(0.0%)
USD 131.87
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 464.37 Million | 249.13 Million | 81.7 Million | 22.53 Million | 60.61 Thousand | - |
| Cost of Revenue | 33.74 Million | 20.44 Million | 8.03 Million | 1.89 Million | 477.12 Thousand | 368.67 Thousand |
| Gross Profit | 430.62 Million | 228.68 Million | 73.67 Million | 20.63 Million | -416.5 Thousand | -368.67 Thousand |
| Operating Expenses | 590 Million | 492.31 Million | 359.36 Million | 251.86 Million | 154.07 Million | 162.26 Million |
| Selling, General and Administrative Expenses | 409.86 Million | 358.78 Million | 272.61 Million | 186.36 Million | 64.94 Million | 30.09 Million |
| Research and Development Expenses | 180.14 Million | 134.71 Million | 88.84 Million | 65.78 Million | 89.12 Million | 132.16 Million |
| Other Expenses | - | -1.18 Million | -2.09 Million | -282.22 Thousand | - | - |
| Cost and Expenses | 623.75 Million | 512.75 Million | 367.39 Million | 253.75 Million | 154.07 Million | 162.26 Million |
| Operating Income | -159.38 Million | -263.62 Million | -285.68 Million | -231.22 Million | -154.01 Million | -162.26 Million |
| Interest Expense | - | 7.37 Million | - | - | - | - |
| Income Tax Expense | 636 Thousand | 6000.00 | 5631.00 | 13.51 Thousand | 1600.00 | 1600.00 |
| Earnings before Tax | -139.03 Million | -256.25 Million | -284.12 Million | -226.99 Million | -147.72 Million | -155.12 Million |
| Net Income | -139.67 Million | -256.25 Million | -284.12 Million | -227 Million | -147.72 Million | -155.12 Million |
| Earnings Per Share Basic | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 | -2.84 |
| Earnings Per Share Diluted | -1.46 | -2.72 | -3.50 | -3.23 | -2.68 | -2.84 |
| Weighted Average Shares Outstanding | 95.88 Million | 94.04 Million | 81.25 Million | 70.36 Million | 55.18 Million | 54.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 95.88 Million | 94.04 Million | 81.25 Million | 70.36 Million | 55.18 Million | 54.7 Million |
| Gross Margin | 0.93 | 0.92 | 0.90 | 0.92 | -6.87 | - |
| EBIT Margin | -0.34 | -1.06 | -3.50 | -10.26 | -2540.90 | - |
| Profit Margin | -0.30 | -1.03 | -3.48 | -10.08 | -2437.14 | - |
| EBITDA | -158.85 Million | -262.97 Million | -285.15 Million | -230.7 Million | -153.53 Million | -161.89 Million |
| Earnings Before Tax Margin | -0.34 | -1.06 | -3.50 | -10.26 | -2540.90 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 175.15 Million | 161.38 Million | 144.86 Million | 131.5 Million | 462.17 Million | 125.81 Million |
| Cost of Revenue | 15.3 Million | 11.35 Million | 9.9 Million | 10.7 Million | 33.74 Million | 9.12 Million |
| Gross Profit | 159.85 Million | 150.03 Million | 134.96 Million | 120.8 Million | 428.43 Million | 116.68 Million |
| Operating Expenses | 198.7 Million | 177.75 Million | 155.91 Million | 154.9 Million | 587.81 Million | 146.39 Million |
| Selling, General and Administrative Expenses | 132.1 Million | 121.57 Million | 113.08 Million | 104.72 Million | - | 105.2 Million |
| Research and Development Expenses | 66.81 Million | 56.18 Million | 42.83 Million | 50.77 Million | - | 41.55 Million |
| Other Expenses | -216 Thousand | -56.18 Million | - | 1.6 Million | - | - |
| Cost and Expenses | 214 Million | 189.11 Million | 165.81 Million | 165.6 Million | 621.55 Million | 155.52 Million |
| Operating Income | -38.84 Million | -27.72 Million | -20.95 Million | -34.09 Million | -159.38 Million | -29.71 Million |
| Interest Expense | - | - | - | 4.34 Million | - | - |
| Income Tax Expense | 374 Thousand | 57 Thousand | 359 Thousand | 448 Thousand | 636 Thousand | 43 Thousand |
| Earnings before Tax | -25.95 Million | -16.16 Million | -14.88 Million | -28.13 Million | -139.03 Million | -24.21 Million |
| Net Income | -26.32 Million | -16.21 Million | -15.24 Million | -28.57 Million | -139.67 Million | -24.25 Million |
| Earnings Per Share Basic | -0.25 | -0.16 | -0.16 | -0.30 | - | -0.25 |
| Earnings Per Share Diluted | -0.25 | -0.16 | -0.16 | -0.30 | - | -0.25 |
| Weighted Average Shares Outstanding | 105.76 Million | 103.72 Million | 96.87 Million | 96.28 Million | 95.88 Million | 96.14 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.76 Million | 103.72 Million | 96.87 Million | 96.28 Million | 95.88 Million | 96.14 Million |
| Gross Margin | 0.91 | 0.93 | 0.93 | 0.92 | 0.93 | 0.93 |
| EBIT Margin | -0.22 | -0.17 | -0.14 | -0.26 | - | -0.24 |
| Profit Margin | -0.15 | -0.10 | -0.11 | -0.22 | -0.30 | -0.19 |
| EBITDA | -38.71 Million | -27.59 Million | -20.82 Million | -33.96 Million | - | -29.57 Million |
| Earnings Before Tax Margin | -0.22 | -0.17 | -0.14 | -0.26 | -0.34 | -0.24 |
WIPL
AWC
MEKKO
CBBI
PSAN
6246